OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $57,000 | -94.9% | 26,362 | -92.1% | 0.00% | -100.0% |
Q3 2021 | $1,124,000 | -70.1% | 334,589 | -34.4% | 0.00% | -83.3% |
Q2 2020 | $3,761,000 | +950.6% | 510,302 | +325.0% | 0.02% | +700.0% |
Q1 2020 | $358,000 | +30.7% | 120,060 | +82.2% | 0.00% | +50.0% |
Q4 2019 | $274,000 | – | 65,906 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |